Renal tubular epithelial cells in all nephron segments express a distinct member of the metalloprotease-disintegrin family, ADAM9 (adisintegrin and metalloprotease 9), in a punctate basolateral distribution co-localized to the β1 integrin chain [Mahimkar, Baricos, Visaya, Pollock and Lovett (2000) J. Am. Soc. Nephrol. 11, 595–603]. Discrete segments of the nephron express several defined β1 integrins, suggesting that ADAM9 interacts with multiple renal integrins and thereby regulates epithelial cell–matrix interactions. Intact ADAM9 and a series of deletion constructs sequentially lacking the metalloprotease domain and the disintegrin domain were assembled as chimaeras with a C-terminal GFP (green fluorescent protein) tag. Stable expression of the ADAM9/GFP protein on the surface of HEK-293 cells (human embryonic kidney 293 cells) significantly decreased adhesion to types I and IV collagen, vitronectin and laminin, but had little effect on adhesion to fibronectin. Expression of the disintegrin/cysteine-rich/GFP construct yielded a similar, but more marked pattern of decreased adhesion. Expression of the cysteine-rich/GFP construct had no effect on adhesion, indicating that the disintegrin domain was responsible for the competitive inhibition of cell–matrix binding. To define the specific renal tubular β1 integrins interacting with the ADAM9 disintegrin domain, a recombinant GST (glutathione S-transferase)-disintegrin protein was used as a substrate in adhesion assays in the presence or absence of specific integrin-blocking antibodies. Inclusion of antibodies to α1, α3, α6, αv and β1 blocked adhesion of HEK-293 cells to GST-disintegrin protein. Immobilized GST-disintegrin domain perfused with renal cortical lysates specifically recovered the α3, α6, αv and β1 integrin chains by Western analysis. It is concluded that ADAM9 is a polyvalent ligand, through its disintegrin domain, for multiple renal integrins of the β1 class.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
January 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
January 07 2005
The disintegrin domain of ADAM9: a ligand for multiple β1 renal integrins Available to Purchase
Rajeev M. MAHIMKAR;
Rajeev M. MAHIMKAR
1Department of Medicine, San Francisco Veterans Administration Medical Center/University of California at San Francisco, 4150 Clement Street, San Francisco, CA 94121, U.S.A.
Search for other works by this author on:
Orvin VISAYA;
Orvin VISAYA
1Department of Medicine, San Francisco Veterans Administration Medical Center/University of California at San Francisco, 4150 Clement Street, San Francisco, CA 94121, U.S.A.
Search for other works by this author on:
Allan S. POLLOCK;
Allan S. POLLOCK
1Department of Medicine, San Francisco Veterans Administration Medical Center/University of California at San Francisco, 4150 Clement Street, San Francisco, CA 94121, U.S.A.
Search for other works by this author on:
David H. LOVETT
David H. LOVETT
1
1Department of Medicine, San Francisco Veterans Administration Medical Center/University of California at San Francisco, 4150 Clement Street, San Francisco, CA 94121, U.S.A.
1To whom correspondence should be addressed (email [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 02 2004
Revision Received:
September 02 2004
Accepted:
September 10 2004
Accepted Manuscript online:
September 10 2004
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London
2005
Biochem J (2005) 385 (2): 461–468.
Article history
Received:
July 02 2004
Revision Received:
September 02 2004
Accepted:
September 10 2004
Accepted Manuscript online:
September 10 2004
Citation
Rajeev M. MAHIMKAR, Orvin VISAYA, Allan S. POLLOCK, David H. LOVETT; The disintegrin domain of ADAM9: a ligand for multiple β1 renal integrins. Biochem J 15 January 2005; 385 (2): 461–468. doi: https://doi.org/10.1042/BJ20041133
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |